Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.

Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH.

Obstet Gynecol. 2019 Oct 8. doi: 10.1097/AOG.0000000000003514. [Epub ahead of print]

PMID:
31599847
2.

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA.

Obstet Gynecol. 2019 Oct 8. doi: 10.1097/AOG.0000000000003500. [Epub ahead of print]

PMID:
31599840
3.

Effects of Timing of Flibanserin Administration Relative to Alcohol Intake in Healthy Premenopausal Women: A Randomized, Double-Blind, Crossover Study.

Simon JA, Clayton AH, Kingsberg SA, Parish SJ, Kim NN, Millheiser L.

J Sex Med. 2019 Sep 12. pii: S1743-6095(19)31365-7. doi: 10.1016/j.jsxm.2019.08.006. [Epub ahead of print]

PMID:
31522985
4.

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects.

Millheiser L, Clayton AH, Parish SJ, Kingsberg SA, Kim NN, Simon JA.

Sex Med. 2019 Sep 10. pii: S2050-1161(19)30127-8. doi: 10.1016/j.esxm.2019.08.003. [Epub ahead of print]

5.

Marcel D. Waldinger, MD, PhD: January 17, 1955 - May 1, 2019.

Balon R, Clayton AH.

J Sex Med. 2019 Sep;16(9):1322-1323. doi: 10.1016/j.jsxm.2019.06.008. Epub 2019 Jul 17. No abstract available.

PMID:
31326305
6.

Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.

Althof S, Derogatis LR, Greenberg S, Clayton AH, Jordan R, Lucas J, Spana C.

J Sex Med. 2019 Aug;16(8):1226-1235. doi: 10.1016/j.jsxm.2019.05.012. Epub 2019 Jul 2.

PMID:
31277966
7.

Lumping, Splitting, and Treating: Therapies Are Needed for Women With Overlapping Sexual Dysfunctions.

Pyke RE, Clayton AH.

Sex Med Rev. 2019 Oct;7(4):551-558. doi: 10.1016/j.sxmr.2019.04.002. Epub 2019 Jun 14. Review.

PMID:
31204297
8.

Female Sexual Dysfunction.

Clayton AH, Valladares Juarez EM.

Med Clin North Am. 2019 Jul;103(4):681-698. doi: 10.1016/j.mcna.2019.02.008. Review.

PMID:
31078200
9.

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III.

Parish SJ, Meston CM, Althof SE, Clayton AH, Goldstein I, Goldstein SW, Heiman JR, McCabe MP, Segraves RT, Simon JA.

J Sex Med. 2019 Mar;16(3):452-462. doi: 10.1016/j.jsxm.2019.01.010.

PMID:
30846116
10.

Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications.

Kingsberg SA, McElroy SL, Clayton AH.

Sex Med Rev. 2019 Jul;7(3):380-392. doi: 10.1016/j.sxmr.2018.12.003. Epub 2019 Feb 22. Review.

PMID:
30803922
11.

The Effect of Nanoparticles on the Cluster Size Distributions of Activated EGFR Measured with Photobleaching Image Correlation Spectroscopy.

Paviolo C, Chon JWM, Clayton AHA.

Adv Exp Med Biol. 2018;1112:41-52. doi: 10.1007/978-981-13-3065-0_4.

PMID:
30637689
12.

The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.

Zanetti-Domingues LC, Korovesis D, Needham SR, Tynan CJ, Sagawa S, Roberts SK, Kuzmanic A, Ortiz-Zapater E, Jain P, Roovers RC, Lajevardipour A, van Bergen En Henegouwen PMP, Santis G, Clayton AHA, Clarke DT, Gervasio FL, Shan Y, Shaw DE, Rolfe DJ, Parker PJ, Martin-Fernandez ML.

Nat Commun. 2018 Oct 18;9(1):4325. doi: 10.1038/s41467-018-06632-0.

13.

Expert opinion on existing and developing drugs to treat female sexual dysfunction.

Miller MK, Smith JR, Norman JJ, Clayton AH.

Expert Opin Emerg Drugs. 2018 Sep;23(3):223-230. doi: 10.1080/14728214.2018.1527901. Epub 2018 Oct 11. Review.

PMID:
30251897
14.

Confocal Microscopy Reveals Cell Surface Receptor Aggregation Through Image Correlation Spectroscopy.

Parslow AC, Clayton AHA, Lock P, Scott AM.

J Vis Exp. 2018 Aug 2;(138). doi: 10.3791/57164.

PMID:
30124657
15.

Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled Trial.

Clayton AH, Tsai J, Mao Y, Pikalov A, Loebel A.

J Clin Psychiatry. 2018 Aug 7;79(5). pii: 18m12132. doi: 10.4088/JCP.18m12132.

16.
17.

Sexual well-being after menopause: An International Menopause Society White Paper.

Simon JA, Davis SR, Althof SE, Chedraui P, Clayton AH, Kingsberg SA, Nappi RE, Parish SJ, Wolfman W.

Climacteric. 2018 Oct;21(5):415-427. doi: 10.1080/13697137.2018.1482647. Epub 2018 Jul 10. Review.

PMID:
29987939
18.

Antimicrobial peptides: biochemical determinants of activity and biophysical techniques of elucidating their functionality.

Shagaghi N, Palombo EA, Clayton AHA, Bhave M.

World J Microbiol Biotechnol. 2018 Apr 12;34(4):62. doi: 10.1007/s11274-018-2444-5. Review.

PMID:
29651655
19.

Conformational Plasticity in Tyrosine Kinase Inhibitor-Kinase Interactions Revealed with Fluorescence Spectroscopy and Theoretical Calculations.

Khattab M, Wang F, Clayton AHA.

J Phys Chem B. 2018 May 3;122(17):4667-4679. doi: 10.1021/acs.jpcb.8b01530. Epub 2018 Apr 20.

PMID:
29629773
20.

Effect Size in Efficacy Trials of Women With Decreased Sexual Desire.

Pyke RE, Clayton AH.

Sex Med Rev. 2018 Jul;6(3):358-366. doi: 10.1016/j.sxmr.2018.01.003. Epub 2018 Mar 22. Review.

PMID:
29576442
21.

The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.

Clayton AH, Goldstein I, Kim NN, Althof SE, Faubion SS, Faught BM, Parish SJ, Simon JA, Vignozzi L, Christiansen K, Davis SR, Freedman MA, Kingsberg SA, Kirana PS, Larkin L, McCabe M, Sadovsky R.

Mayo Clin Proc. 2018 Apr;93(4):467-487. doi: 10.1016/j.mayocp.2017.11.002. Epub 2018 Mar 12. Review.

22.

Sex Differences in the Treatment of Sexual Dysfunction.

Harsh V, Clayton AH.

Curr Psychiatry Rep. 2018 Mar 14;20(3):18. doi: 10.1007/s11920-018-0883-1. Review.

PMID:
29541946
23.

Evaluation and Management of Hypoactive Sexual Desire Disorder.

Clayton AH, Kingsberg SA, Goldstein I.

Sex Med. 2018 Jun;6(2):59-74. doi: 10.1016/j.esxm.2018.01.004. Epub 2018 Mar 6. Review.

24.

Assessment of Sexual Desire for Clinical Trials of Women With Hypoactive Sexual Desire Disorder: Measures, Desire-Related Behavior, and Assessment of Clinical Significance.

Pyke RE, Clayton AH.

Sex Med Rev. 2018 Jul;6(3):367-383. doi: 10.1016/j.sxmr.2017.11.008. Epub 2018 Jan 19. Review.

PMID:
29371145
25.

Exploring oligomeric state of the serotonin1A receptor utilizing photobleaching image correlation spectroscopy: implications for receptor function.

Chakraborty H, Jafurulla M, Clayton AHA, Chattopadhyay A.

Faraday Discuss. 2018 Apr 1;207:409-421. doi: 10.1039/c7fd00192d. Epub 2018 Jan 23.

PMID:
29359206
26.

Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.

Clayton AH, Croft HA, Yuan J, Brown L, Kissling R.

J Sex Med. 2018 Jan;15(1):43-51. doi: 10.1016/j.jsxm.2017.11.005.

27.
28.

Corrigendum.

Clayton AH, Pyke RE.

J Sex Marital Ther. 2019;45(7):662. doi: 10.1080/0092623X.2017.1399652. Epub 2019 Feb 1. No abstract available.

PMID:
29095125
29.

Single Nucleotide Polymorphisms and the Central Nervous System: Potential Biomarkers in Identifying Suicide Risk.

Yarlagadda A, Rosenblatt KP, Clayton AH.

Innov Clin Neurosci. 2017 Jun 1;14(5-6):21-24. eCollection 2017 May-Jun. Review.

30.

Flibanserin: From Bench to Bedside.

Dooley EM, Miller MK, Clayton AH.

Sex Med Rev. 2017 Oct;5(4):461-469. doi: 10.1016/j.sxmr.2017.06.003. Epub 2017 Jul 27. Review.

31.

Women's Mental Health: Progress and Realities.

Kornstein SG, Clayton AH.

Psychiatr Clin North Am. 2017 Jun;40(2):xiii-xiv. doi: 10.1016/j.psc.2017.03.001. Epub 2017 Mar 25. No abstract available.

PMID:
28477658
32.

Female Sexual Dysfunction.

Clayton AH, Valladares Juarez EM.

Psychiatr Clin North Am. 2017 Jun;40(2):267-284. doi: 10.1016/j.psc.2017.01.004. Epub 2017 Mar 25. Review.

PMID:
28477652
33.

Clinical role of brexpiprazole in depression and schizophrenia.

Parikh NB, Robinson DM, Clayton AH.

Ther Clin Risk Manag. 2017 Mar 10;13:299-306. doi: 10.2147/TCRM.S94060. eCollection 2017. Review.

34.

Revealing the sequence of interactions of PuroA peptide with Candida albicans cells by live-cell imaging.

Shagaghi N, Bhave M, Palombo EA, Clayton AH.

Sci Rep. 2017 Mar 2;7:43542. doi: 10.1038/srep43542.

35.

Interactions of a lytic peptide with supported lipid bilayers investigated by time-resolved evanescent wave-induced fluorescence spectroscopy.

Rapson AC, Gee ML, Clayton AH, Smith TA.

Methods Appl Fluoresc. 2016 Sep 28;4(4):044001. doi: 10.1088/2050-6120/4/4/044001.

PMID:
28192294
36.

Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants.

Clayton AH, Lucas J, DeRogatis LR, Jordan R.

Clin Ther. 2017 Mar;39(3):514-526.e14. doi: 10.1016/j.clinthera.2017.01.018. Epub 2017 Feb 9.

37.

Quantitative and Qualitative Research in HSDD: The Difference Between Testing Theory and Generating New Theories.

Clayton AH, Pyke RE.

J Sex Marital Ther. 2017 Apr 3;43(3):223-227. doi: 10.1080/0092623X.2017.1283379. Epub 2017 Jan 23.

PMID:
28113002
38.

Is Flibanserin Meaningfully Superior to Placebo?

Clayton AH, Pyke RE.

J Sex Marital Ther. 2017 Apr 3;43(3):218-222. doi: 10.1080/0092623X.2017.1280865. Epub 2017 Jan 11. No abstract available. Erratum in: J Sex Marital Ther. 2017 Nov 2;:1.

PMID:
28075707
39.

Thoughts on the U.S. Food and Drug Administration (FDA) Draft Guidance on Low Sexual Desire and Arousal.

Goldstein I, Fisher WA, Kim NN, Kingsberg SA, Clayton AH, Sand M, Rosen RC, Goldstein SW.

Sex Med Rev. 2017 Jan;5(1):1-2. doi: 10.1016/j.sxmr.2016.11.003. No abstract available.

PMID:
28024687
40.

Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.

Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R.

Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1. Review.

41.

Imaging Cellular Dynamics with Spectral Relaxation Imaging Microscopy: Distinct Spectral Dynamics in Golgi Membranes of Living Cells.

Lajevardipour A, Chon JW, Chattopadhyay A, Clayton AH.

Sci Rep. 2016 Nov 22;6:37038. doi: 10.1038/srep37038.

42.

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.

Parish SJ, Goldstein AT, Goldstein SW, Goldstein I, Pfaus J, Clayton AH, Giraldi A, Simon JA, Althof SE, Bachmann G, Komisaruk B, Levin R, Spadt SK, Kingsberg SA, Perelman MA, Waldinger MD, Whipple B.

J Sex Med. 2016 Dec;13(12):1888-1906. doi: 10.1016/j.jsxm.2016.09.020. Epub 2016 Nov 11.

PMID:
27843072
43.

EGFR oligomerization organizes kinase-active dimers into competent signalling platforms.

Needham SR, Roberts SK, Arkhipov A, Mysore VP, Tynan CJ, Zanetti-Domingues LC, Kim ET, Losasso V, Korovesis D, Hirsch M, Rolfe DJ, Clarke DT, Winn MD, Lajevardipour A, Clayton AH, Pike LJ, Perani M, Parker PJ, Shan Y, Shaw DE, Martin-Fernandez ML.

Nat Commun. 2016 Oct 31;7:13307. doi: 10.1038/ncomms13307.

44.

Standards in Studies of Psychotherapy and Pharmacotherapy Interventions for HSDD.

Clayton AH, Pyke RE.

J Sex Marital Ther. 2017 Apr 3;43(3):206-209. doi: 10.1080/0092623X.2016.1217296. Epub 2016 Sep 20. No abstract available.

PMID:
27649260
45.

Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study.

Clayton AH, Durgam S, Li D, Chen C, Chen L, Mathews M, Gommoll CP, Szegedi A.

Int Clin Psychopharmacol. 2017 Jan;32(1):27-35.

46.

Sexual Dysfunction Due to Psychotropic Medications.

Clayton AH, Alkis AR, Parikh NB, Votta JG.

Psychiatr Clin North Am. 2016 Sep;39(3):427-63. doi: 10.1016/j.psc.2016.04.006. Epub 2016 Jul 2. Review.

PMID:
27514298
47.

Solvatochromism and linear solvation energy relationship of the kinase inhibitor SKF86002.

Khattab M, Van Dongen M, Wang F, Clayton AH.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jan 5;170:226-33. doi: 10.1016/j.saa.2016.07.027. Epub 2016 Jul 17.

PMID:
27450120
48.

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies.

Clayton AH, Durgam S, Tang X, Chen C, Ruth A, Gommoll C.

Neuropsychiatr Dis Treat. 2016 Jun 21;12:1467-76. doi: 10.2147/NDT.S103408. eCollection 2016.

49.

Direct Measurement of Pore Dynamics and Leakage Induced by a Model Antimicrobial Peptide in Single Vesicles and Cells.

Burton MG, Huang QM, Hossain MA, Wade JD, Palombo EA, Gee ML, Clayton AH.

Langmuir. 2016 Jun 28;32(25):6496-505. doi: 10.1021/acs.langmuir.6b00596. Epub 2016 Jun 17.

PMID:
27281288
50.

Anti-biofilm and sporicidal activity of peptides based on wheat puroindoline and barley hordoindoline proteins.

Shagaghi N, Alfred RL, Clayton AH, Palombo EA, Bhave M.

J Pept Sci. 2016 Jul;22(7):492-500. doi: 10.1002/psc.2895. Epub 2016 May 30.

PMID:
27238815

Supplemental Content

Loading ...
Support Center